ABIONYX Pharma SA (EPA:ABNX)
France · Delayed Price · Currency is EUR 2.220
-0.010 (-0.45%)
Jun 23, 2026, 5:35 PM CET
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €78.35 million as of June 23, 2026. Its market cap has increased by 81.04% in one year.
Market Cap
78.35M
Enterprise Value
78.63M
Revenue
4.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.22
Market Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 78.35M, a decrease of -63.42%. That is a compound annual growth rate of -8.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 78.35M | -41.32% |
| Dec 31, 2025 | 133.53M | 223.58% |
| Dec 31, 2024 | 41.27M | -0.54% |
| Dec 29, 2023 | 41.49M | -14.37% |
| Dec 30, 2022 | 48.45M | -28.38% |
| Dec 31, 2021 | 67.65M | 178.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Transgene | 204.59M |
| Cellectis | 193.85M |
| Innate Pharma | 150.88M |
| Sensorion | 126.36M |
| Valerio Therapeutics Société anonyme | 103.39M |
| OSE Immunotherapeutics | 82.13M |
| Adocia | 80.22M |
| MaaT Pharma | 53.80M |